Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

New cancers after autotransplantations for multiple myeloma.

Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN.

Biol Blood Marrow Transplant. 2015 Apr;21(4):738-45. doi: 10.1016/j.bbmt.2014.12.028. Epub 2014 Dec 31.

2.

Italian cancer figures, report 2013: Multiple tumours.

AIRTUM Working Group.

Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. English, Italian.

3.

Increased incidence of a second lymphoproliferative malignancy in patients with multiple myeloma--a SEER based study.

Chakraborty S, Hauke RJ, Bonthu N, Tarantolo SR.

Anticancer Res. 2012 Oct;32(10):4507-15.

PMID:
23060579
4.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

5.

Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.

Ishida Y, Qiu D, Maeda M, Fujimoto J, Kigasawa H, Kobayashi R, Sato M, Okamura J, Yoshinaga S, Rikiishi T, Shichino H, Kiyotani C, Kudo K, Asami K, Hori H, Kawaguchi H, Inada H, Adachi S, Manabe A, Kuroda T.

Int J Clin Oncol. 2016 Jun;21(3):506-16. doi: 10.1007/s10147-015-0927-z. Epub 2015 Nov 30.

PMID:
26620038
6.

Associations between ocular melanoma and other primary cancers: an international population-based study.

Scélo G, Boffetta P, Autier P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Chia KS, Jonasson JG, Martos C, Giblin M, Brennan P.

Int J Cancer. 2007 Jan 1;120(1):152-9.

7.

Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data.

Tabuchi T, Ito Y, Ioka A, Miyashiro I, Tsukuma H.

Cancer Sci. 2012 Jun;103(6):1111-20. doi: 10.1111/j.1349-7006.2012.02254.x. Epub 2012 Apr 11.

8.

Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.

Ai WZ, Keegan TH, Press DJ, Yang J, Pincus LB, Kim YH, Chang ET.

JAMA Dermatol. 2014 Jul;150(7):709-15. doi: 10.1001/jamadermatol.2013.7747.

9.

Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.

Werner-Wasik M, Schmid CH, Bornstein LE, Madoc-Jones H.

Cancer. 1995 May 1;75(9):2281-5.

PMID:
7712437
10.

Leukemias, myeloma, and other lymphoreticular neoplasms.

Hernández JA, Land KJ, McKenna RW.

Cancer. 1995 Jan 1;75(1 Suppl):381-94.

PMID:
8001009
11.

Incidence of second cancers in patients treated for Hodgkin's disease.

Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P, et al.

J Natl Cancer Inst. 1995 May 17;87(10):732-41.

PMID:
7563150
12.

The Shreveport Myeloma Experience: Survival, Risk Factors and Other Malignancies in the Age of Stem Cell Transplantation.

Munker R, Shi R, Nair B, Devarakonda S, Cotelingam JD, McLarty J, Mills GM, Glass J.

Acta Haematol. 2016;135(3):146-55. doi: 10.1159/000440970. Epub 2015 Nov 21.

PMID:
26588024
13.

Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).

Mailankody S, Pfeiffer RM, Kristinsson SY, Korde N, Bjorkholm M, Goldin LR, Turesson I, Landgren O.

Blood. 2011 Oct 13;118(15):4086-92. doi: 10.1182/blood-2011-05-355743. Epub 2011 Jul 27.

14.
15.

New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.

Socié G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, Sullivan KM, Rowlings PA, Kingma DW, Banks PM, Travis WD, Witherspoon RP, Sanders J, Jaffe ES, Horowitz MM.

J Clin Oncol. 2000 Jan;18(2):348-57.

PMID:
10637249
16.

Risk of skin cancer in multiple myeloma patients: a retrospective cohort study.

Robinson AA, Wang J, Vardanyan S, Madden EK, Hebroni F, Udd KA, Spektor TM, Nosrati JD, Kitto AZ, Zahab M, Cheema S, Fors DH, Norberg A, Diehl J, Waterman GN, Swift RA, Crowley J, Berenson JR.

Eur J Haematol. 2016 Nov;97(5):439-444. doi: 10.1111/ejh.12748. Epub 2016 Mar 7.

PMID:
26872804
17.

Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States).

Gebregziabher M, Bernstein L, Wang Y, Cozen W.

Cancer Causes Control. 2006 Sep;17(7):931-8.

PMID:
16841260
18.

Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.

Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, Joensuu T, van Leeuwen FE, van't Veer MB, Curtis RE, Holowaty EJ, Andersson M, Wiklund T, Gospodarowicz M, Travis LB.

J Clin Oncol. 2000 Jun;18(12):2435-43.

PMID:
10856104
19.

Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.

Olsen JH, Möller T, Anderson H, Langmark F, Sankila R, Tryggvadóttír L, Winther JF, Rechnitzer C, Jonmundsson G, Christensen J, Garwicz S.

J Natl Cancer Inst. 2009 Jun 3;101(11):806-13. doi: 10.1093/jnci/djp104. Epub 2009 May 26.

PMID:
19470947
20.

New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors.

Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL.

J Clin Oncol. 2003 Apr 1;21(7):1352-8. Erratum in: J Clin Oncol. 2003 Aug 15;21(16):3181.

PMID:
12663726

Supplemental Content

Support Center